IG
IGC icon

ING Group’s IGC Pharma IGC Stock Holding History

ING Group’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,000
Closed -$97K – 766
2018
Q3 		$97K Buy
+15,000
New +$15.6K ﹤0.01% 751

Other funds holding IGC

CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

ING Group's IGC Position: Q4 2018 in Review

ING Group sold out of IGC Pharma (IGC) in Q4 2018, closing a stake of 15,000 shares — an estimated $97K sold.

ING Group first reported a position in IGC in Q3 2018 and held it in 1 quarter. The position peaked at $97K in Q3 2018. 4 funds tracked by Wall St. Rank hold IGC as of Q4 2018.

  • ING Group reported no remaining IGC Pharma position as of Q4 2018 after selling out during the quarter.
  • ING Group sold 15,000 IGC Pharma shares in Q4 2018, an estimated $97K.
  • ING Group first reported a position in IGC Pharma in Q3 2018 and held it in 1 quarter.
  • ING Group's IGC Pharma position peaked at $97K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2018.

Based on ING Group's 13F filing for Q4 2018, filed 13 Feb 2019.